Gastroenterology

Gastroenterology

Volume 92, Issue 4, April 1987, Pages 1027-1036
Gastroenterology

Low-Dose Trazodone for Symptomatic Patients With Esophageal Contraction Abnormalities: A Double-Blind, Placebo-Controlled Trial

https://doi.org/10.1016/0016-5085(87)90979-6Get rights and content

Twenty-nine patients with esophageal symptoms and contraction abnormalities of the esophageal body completed a 6-wk, double-blind, placebocontrolled trial of trazodone (100–150 mg1day). Measures of esophageal and psychologic symptoms were completed at entry and at each follow-up visit. Esophageal manometry was repeated at the termination of the trial. Upon completion of the treatment, patients receiving trazodone (n = 15) reported a significantly greater global improvement than those receiving placebo (n =14; p = 0.02). Although a variable clinical response was observed, the trazodone group had less residual distress over esophageal symptoms compared with the placebo group (59% ± 9% vs. 108% ± 19%, p = 0.03). Manometric changes observed during the course of the trial were not influenced by treatment nor by clinical response. Remarkable reductions in ratings of chest pain were reported by both treatment groups, emphasizing the importace of controlled trials when studying this patient population. We conclude that low-dose trazodone therapy can be of benefit in the management of symptomatic patients with esophageal contraction abnormalities. In addition, our findings support recent observations that manometric abnormalities characterizing this patient group may not be solely responsible for symptoms.

References (50)

  • JE Richter et al.

    Verapamil-a potent inhibitor, of esophageal contractions in the baboon

    Gastroenterology

    (1982)
  • RE Clouse et al.

    Contraction abnormalities of the esophageal body in patients referred for manometry: a new approach to manometric classification

    Dig Dis Sci

    (1983)
  • JP Harrington et al.

    Chest pain and dysphagia in patients with prolonged peristaltic contractile duration of the esophagus

    Dig Dis Sci

    (1984)
  • WL Reidel et al.

    Variations in clinical presentation of patients with esophageal contraction abnormalities

    Dig Dis Sci

    (1985)
  • RC Orlando et al.

    Clinical and manometric effects of nitroglycerin in diffuse esophageal spasm

    N Engl J Med

    (1973)
  • WA Parker et al.

    Nitrites in the treatment of diffuse esophageal spasm

    Drug intell Clin Pharm

    (1981)
  • SM Nasrallah et al.

    Primary esophageal motor disorders: clinical response to nifedipine

    South Med J

    (1985)
  • G Cargill et al.

    Nifedipine for relief of esophageal chest pain?

    N Engl J Med

    (1982)
  • HA Davies et al.

    Nifedipine for relief of esophageal chest pain?

    N Engl J Med

    (1982)
  • SM Nasrallah

    Nifedipine in the treatment of diffuse oesophageal spasm

    Lancet

    (1982)
  • JE Richter et al.

    Effects of oral calcium blocker, diltiazem, on esophageal contractions

    Dig Dis Sci

    (1984)
  • BD Silverstein et al.

    Treatment of esophageal motor disorders with a calcium-blocker, diltiazem (abstr)

    Gastroenterology

    (1982)
  • JE Richter et al.

    Nifedipine: a potent inhibitor of esophageal contractions

    Is it effective in the treatment of non-cardiac chest pain (abstr)? Dig Dis Sci

    (1985)
  • RE Clouse et al.

    Psychiatric illness and contraction abnormalities of the esophagus

    N Engl J Med

    (1983)
  • JL Liss et al.

    The irritable colon syndrome and psychiatric illness

    Dis Nerv Syst

    (1973)
  • Cited by (307)

    • Esophageal hypersensitivity

      2023, Handbook of Gastrointestinal Motility and Disorders of Gut-Brain Interactions, Second Edition
    • The role of serotonin and its pathways in gastrointestinal disorders

      2021, The Complex Interplay Between Gut-Brain, Gut-Liver, and Liver-Brain Axes
    • The interactions between gut and brain in gastrointestinal disorders

      2021, The Complex Interplay Between Gut-Brain, Gut-Liver, and Liver-Brain Axes
    View all citing articles on Scopus

    This work, was supported in part by grants AM07130, AM31496, and RR00036 (General Clinical Research Center) from the U.S. Public Health Service.

    The authors thank Mary Fahy, Melanie Alpers, and Suzanne Hudson for assistance with the motility studies and Beverly Field and Gary Harper for assistance in administering the psychiatric interviews reported in this investigation.

    View full text